Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valsamo K Anagnostou

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2015
Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancerValsamo K Anagnostou, Julie R Brahmer
Applied Clinical Informatics|May 10, 2011
Developing a multivariable prognostic model for pancreatic endocrine tumors using the clinical data warehouse resources of a single institutionTaxiarchis Botsis, Valsamo K Anagnostou, Gunnar Hartvigsen, et al.
Cancer Informatics|May 29, 2010
Modeling prognostic factors in resectable pancreatic adenocarcinomasTaxiarchis Botsis, Valsamo K Anagnostou, Gunnar Hartvigsen, et al.
Virchows Archiv : an International Journal of Pathology|December 17, 2010
Multiplexed analysis of angiogenesis and lymphangiogenesis factors predicts outcome for non-small cell lung cancer patientsValsamo K Anagnostou, Dina G Tiniakos, Marianthi Fotinou, et al.
Connecticut Medicine|March 8, 2014
A longitudinal, collaborative, practice-based learning and improvement model to improve post-discharge heart failure outcomesValsamo K Anagnostou, Grant Bailey, Edward Sze, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinomaValsamo K Anagnostou, Konstantinos N Syrigos, Gerold Bepler, et al.
Archives of Pathology & Laboratory Medicine|April 7, 2010
Quantitative evaluation of protein expression as a function of tissue microarray core diameter: is a large (1.5 mm) core better than a small (0.6 mm) core?Valsamo K Anagnostou, Frank J Lowery, Konstantinos N Syrigos, et al.
European Journal of Endocrinology|October 26, 2011
Mechanisms in endocrinology: primary HT and risk for breast cancer: a systematic review and meta-analysisAnna G Angelousi, Valsamo K Anagnostou, Michael K Stamatakos, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|April 18, 2007
Ontogeny of intrinsic innervation in the human thymus and spleenValsamo K Anagnostou, Ipatia Doussis-Anagnostopoulou, Dina G Tiniakos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinomaValsamo K Anagnostou, Gerold Bepler, Konstantinos N Syrigos, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2015
Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancerValsamo K Anagnostou, Julie R Brahmer
Applied Clinical Informatics|May 10, 2011
Developing a multivariable prognostic model for pancreatic endocrine tumors using the clinical data warehouse resources of a single institutionTaxiarchis Botsis, Valsamo K Anagnostou, Gunnar Hartvigsen, et al.
Cancer Informatics|May 29, 2010
Modeling prognostic factors in resectable pancreatic adenocarcinomasTaxiarchis Botsis, Valsamo K Anagnostou, Gunnar Hartvigsen, et al.
Virchows Archiv : an International Journal of Pathology|December 17, 2010
Multiplexed analysis of angiogenesis and lymphangiogenesis factors predicts outcome for non-small cell lung cancer patientsValsamo K Anagnostou, Dina G Tiniakos, Marianthi Fotinou, et al.
Connecticut Medicine|March 8, 2014
A longitudinal, collaborative, practice-based learning and improvement model to improve post-discharge heart failure outcomesValsamo K Anagnostou, Grant Bailey, Edward Sze, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinomaValsamo K Anagnostou, Konstantinos N Syrigos, Gerold Bepler, et al.
Archives of Pathology & Laboratory Medicine|April 7, 2010
Quantitative evaluation of protein expression as a function of tissue microarray core diameter: is a large (1.5 mm) core better than a small (0.6 mm) core?Valsamo K Anagnostou, Frank J Lowery, Konstantinos N Syrigos, et al.
European Journal of Endocrinology|October 26, 2011
Mechanisms in endocrinology: primary HT and risk for breast cancer: a systematic review and meta-analysisAnna G Angelousi, Valsamo K Anagnostou, Michael K Stamatakos, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|April 18, 2007
Ontogeny of intrinsic innervation in the human thymus and spleenValsamo K Anagnostou, Ipatia Doussis-Anagnostopoulou, Dina G Tiniakos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinomaValsamo K Anagnostou, Gerold Bepler, Konstantinos N Syrigos, et al.
Pageof 2